Chronic News and Research

RSS

Catholic Charities USA convenes Centennial Summit in San Antonio

Catholic Charities USA, the 170-member national human services organization committed to cutting poverty in half by 2020–hosted by Catholic Charities, Archdiocese of San Antonio, Inc. and joined by Catholic Charities agencies from around the region–convened one of 10 Centennial Summits in San Antonio today as part of the organization's 100 year history.

22 Jan 2010

Focused Ultrasound Surgery Foundation disbursed $1 million in research awards; looks forward to fund more projects in 2010

The Focused Ultrasound Surgery Foundation has disbursed nearly $1 million in research awards for work on a breakthrough medical technology and is making more project funding available in 2010.

22 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Study: Chinese anesthesiologists willing to help patients quit smoking, reduce tobacco-related deaths

The statistics are frightening: one-third of the world's smokers (300 million) live in China, and chronic diseases caused by smoking are a growing burden to public health there. Current projections estimate that the number of tobacco-related deaths in China will increase to 2 million annually by 2025.

22 Jan 2010

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper “An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure” was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).

22 Jan 2010

Researchers to study the impact of asthma on sleep and academic performance of young children

Bradley Hasbro Children's Research Center and Hasbro Children's Hospital researchers have received more than $2.5 million in direct costs from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to study the impact of asthma on the sleep quality and academic performance of young children.

22 Jan 2010

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

Low vitamin D blood levels are associated with a significantly higher risk of relapse attacks in patients with multiple sclerosis (MS) who develop the disease during childhood, according to a study conducted by researchers from the University of California, San Francisco.

22 Jan 2010

CytRx announces its plans to advance multiple oncology development programs in 2010

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced its plans for 2010 aimed at advancing the clinical development of its high-value drug development pipeline and enhancing shareholder value.

22 Jan 2010

Mice study shows obesity can increase risk of developing liver cancer

Obesity comes with plenty of health risks, but there's one that's perhaps not so well known: an increased risk of developing cancer, and especially certain types of cancer like liver cancer. Now, a group of researchers reporting in the January 22nd issue of the journal Cell, a Cell Press publication, have confirmed in mice that obesity does indeed act as a "bona fide tumor promoter." They also have good evidence to explain how that happens.

22 Jan 2010

New study shows VBID program can save money

Value-based insurance design programs — which reduce patient co-payments for highly effective treatments — can break even financially or possibly save money, according to a new study from University of Michigan, Harvard and other researchers.

22 Jan 2010

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.

21 Jan 2010

Reuters examines chronic disease in developing countries, future of drug prices

"Global health projections leave little doubt that chronic diseases are rapidly overtaking infectious diseases, such as malaria, AIDS and tuberculosis (TB), as the world's biggest killers - a shift emphasized by a recent World Health Organization (WHO) report on global health risks," Reuters writes in a story analyzing the future of drug pricing in the developing world. Longer life-spans in developing countries "and changing patterns of food, alcohol and tobacco consumption are creating a 'double burden' for poor nations, piling chronic diseases on top of infectious diseases," the news service writes.

21 Jan 2010

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA.

21 Jan 2010

Elevation Pharmaceuticals closes $30M tranched Series A financing

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing.

21 Jan 2010

Pharmasset commences PSI-7977 Phase 2a trial for HCV

Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.

21 Jan 2010

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.

21 Jan 2010

UnitedHealth Group announces its revenues and net earnings in 2009

UnitedHealth Group today reported growth in revenues and net earnings per share in 2009. The Company earned $0.81 per share in the fourth quarter, bringing full year 2009 net earnings to $3.24 per share.

21 Jan 2010

Special report on A-Fib to be premiered in RLTV's Healthline series

Retirement Living TV's (RLTV) award-winning series, Healthline will premiere a special report on Atrial Fibrillation. This half-hour episode explores the possible symptoms, risk factors and treatments to successfully live with this chronic illness.

21 Jan 2010

COTI's novel small molecule effective against pancreatic cancer in animal model

Critical Outcome Technologies Inc. announced more positive results today from animal experiments carried out at a prominent Canadian cancer research facility. This new series of experiments adds to the impressive data package for COTI-2, demonstrating efficacy both as a single agent and in combination with current first line therapies, as well as low toxicity in several different animal models of human cancers.

21 Jan 2010

Engaging in incentive-based wellness program is associated with lower healthcare costs

According to a study published in the January/February issue of the American Journal of Health Promotion, a peer-reviewed journal devoted to health promotion, health plan members who participated in fitness-related activities within an incentive-based health insurance wellness program had significantly lower healthcare costs.

21 Jan 2010

Chronic News and Research

Catholic Charities USA convenes Centennial Summit in San Antonio

Focused Ultrasound Surgery Foundation disbursed $1 million in research awards; looks forward to fund more projects in 2010

The American Journal of Pathology: Highlights from February 2010 issue

Study: Chinese anesthesiologists willing to help patients quit smoking, reduce tobacco-related deaths

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

Researchers to study the impact of asthma on sleep and academic performance of young children

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

CytRx announces its plans to advance multiple oncology development programs in 2010

Mice study shows obesity can increase risk of developing liver cancer

New study shows VBID program can save money

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

Reuters examines chronic disease in developing countries, future of drug prices

China Pharma Holdings announces completion of clinical trials for Candesartan

Elevation Pharmaceuticals closes $30M tranched Series A financing

Pharmasset commences PSI-7977 Phase 2a trial for HCV

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

UnitedHealth Group announces its revenues and net earnings in 2009

Special report on A-Fib to be premiered in RLTV's Healthline series

COTI's novel small molecule effective against pancreatic cancer in animal model

Engaging in incentive-based wellness program is associated with lower healthcare costs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News